Il10 Deficiency Rebalances Innate Immunity to Mitigate Alzheimer-Like Pathology

Interleukin-10-deficient mice develop chronic enterocolitis

Kühn, R., Löhler, J., Rennick, D. M., Rajewsky, K., & Müller, W. (1993) · Cell · doi:10.1016/0092-8674(93)80068-p · Cited by 4,248

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210

Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160

Open source clustering software

de Hoon, M., Imoto, S., Nolan, J., & Miyano, S. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth078 · Cited by 3,047

Identification of a unique TGF-β–dependent molecular and functional signature in microglia

Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543

Renal and Extrarenal Effects of Gum Arabic (Acacia Senegal) - What Can be Learned from Animal Experiments?

Nasir, O. (2013) · Kidney & Blood Pressure Research · doi:10.1159/000350152 · Cited by 2,331

Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease

Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078

Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012

Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease

Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657

Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase

Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575

Essential Dietary Bioactive Lipids in Neuroinflammatory Diseases

Catani, M. V., Gasperi, V., Bisogno, T., & Maccarrone, M. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6958 · Cited by 28

The interactive effect of genetic polymorphisms of IL-10 and COMT on cognitive function in schizophrenia

Wang, J., Xu, H., Wang, D., Wei, G., Zhou, H., Wang, L., Zhou, Y., & Zhang, X. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.10.021 · Cited by 27

Increase in the Inflammatory Marker GlycA over 13 Years in Young Adults Is Associated with Poorer Cognitive Function in Midlife

Cohen‐Manheim, I., Doniger, G. M., Sinnreich, R., Simon, E. S., Pinchas‐Mizrachi, R., Otvos, J. D., & Kark, J. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138036 · Cited by 27

Staging Alzheimer’s Disease in the Brain and Retina of B6.APP/PS1 Mice by Transcriptional Profiling

Chintapaludi, S. R., Uyar, A., Jackson, H. M., Acklin, C. J., Wang, X., Sasner, M., Carter, G. W., & Howell, G. R. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-190793 · Cited by 25

Let’s make microglia great again in neurodegenerative disorders

Guillot‐Sestier, M., & Town, T. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1792-x · Cited by 26

Neuroinflammation across the Spectrum of Neurodegenerative Diseases: Mechanisms and Therapeutic Frontiers

Alemán-Villa, K. M., Armienta-Rojas, D. A., Camberos-Barraza, J., Rábago-Monzón, Á. R., Camacho-Zamora, A., Osuna‐Ramos, J. F., Magaña‐Gómez, J. A., Guadrón‐Llanos, A. M., Calderón-Zamora, L., Norzagaray-Valenzuela, C. D., et al. (2025) · NeuroImmunoModulation · doi:10.1159/000548021 · Cited by 34

Intranasal administration of Ganoderma lucidum-derived exosome-like nanovesicles ameliorates cognitive impairment by reducing inflammation in a mouse model of Alzheimer’s disease

Mi, X., Ruan, X., Lin, R., Huang, S., Cai, P., Chen, X., Liao, J., & Dai, X. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1572771 · Cited by 26

Differential roles of regulatory T cells in Alzheimer's disease

Jafarzadeh, A., Sheikhi, A., Jafarzadeh, Z., & Nemati, M. (2023) · Cellular Immunology · doi:10.1016/j.cellimm.2023.104778 · Cited by 26

Mapping the Plasticity of Morphology, Molecular Properties and Function in Mouse Primary Microglia

Jiang, X., He, H., Mo, L., Liu, Q., Yang, F., Zhou, Y., Li, L., Su, D., Yi, S., & Zhang, J. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.811061 · Cited by 23

Therapeutic anti‐amyloid β antibodies cause neuronal disturbances

Adhikari, U. K., Khan, R. H., Mikhael, M., Balez, R., David, M. A., Mahns, D. A., Hardy, J., & Tayebi, M. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12833 · Cited by 24

VEGF-A in serum protects against memory impairment in APP/PS1 transgenic mice by blocking neutrophil infiltration

Qi, F., Zuo, Z., Hu, K., Wang, R., Wu, T., Liu, H., Tang, J., Wang, Q., Xie, Y., Tan, L., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02097-w · Cited by 24

Inverse Relationship Between Alzheimer’s Disease and Cancer: How Immune Checkpoints Might Explain the Mechanisms Underlying Age-Related Diseases

Rogers, N. K., Romero, C., SanMartín, C. D., Ponce, D. P., Salech, F., López, M. N., Gleisner, M. A., Tempio, F., & Behrens, M. I. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190839 · Cited by 23

Mesenchymal stem cell-derived extracellular vesicles alleviate autism by regulating microglial glucose metabolism reprogramming and neuroinflammation through PD-1/PD-L1 interaction

Qin, Q., Fan, L., Zeng, X., Zheng, D., Wang, H., Li, M., Jiang, Y., Wang, H., Liu, H., Liang, S., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03250-z · Cited by 24

Reactive Astrocytes Contribute to Alzheimer’s Disease-Related Neurotoxicity and Synaptotoxicity in a Neuron-Astrocyte Co-culture Assay

Wasilewski, D., Villalba‐Moreno, N. D., Stange, I., Glatzel, M., Falla, D. S., & Krasemann, S. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.739411 · Cited by 23

Microglia-Synapse Pathways: Promising Therapeutic Strategy for Alzheimer’s Disease

Xie, J., Wang, H., Lin, T., & Bi, B. (2017) · BioMed Research International · doi:10.1155/2017/2986460 · Cited by 22

Novel Influences of IL-10 on CNS Inflammation Revealed by Integrated Analyses of Cytokine Networks and Microglial Morphology

Anderson, W. D., Greenhalgh, A. D., Takwale, A., David, S., & Vadigepalli, R. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00233 · Cited by 22

CRISPR/Cas9-mediated CysLT1R deletion reverses synaptic failure, amyloidosis and cognitive impairment in APP/PS1 mice

Chen, F., Fang, S., Du, Y., Ghosh, A., Reed, M. N., Long, Y., Suppiramaniam, V. D., Tang, S., & Hong, H. (2021) · Aging · doi:10.18632/aging.202501 · Cited by 21

A pathogenic role for IL-10 signalling in capillary stalling and cognitive impairment in type 1 diabetes

Sharma, S., Cheema, M. S., Reeson, P. L., Narayana, K., Boghozian, R., Cota, A. P., Brosschot, T. P., FitzPatrick, R. D., Körbelin, J., Reynolds, L. A., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01159-9 · Cited by 23

Hypoperfusion is a potential inducer of immunosuppressive network in Alzheimer's disease

Salminen, A. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104919 · Cited by 20

Bacille Calmette-Guérin attenuates vascular amyloid pathology and maximizes synaptic preservation in APP/PS1 mice following active amyloid-β immunotherapy

Zuo, Z., Qi, F., Xing, Z., Yuan, L., Yang, Y., He, Z., Zhou, L., & Yao, Z. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.01.001 · Cited by 19

Targeting galectin-3 to counteract spike-phase uncoupling of fast-spiking interneurons to gamma oscillations in Alzheimer’s disease

Arroyo‐García, L. E., Bachiller, S., Ruiz, R., Boza‐Serrano, A., Moreno, A. R., Deierborg, T., Andrade‐Talavera, Y., & Fisahn, A. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00338-0 · Cited by 22

Microglia

Perry, V. H. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0003-2015 · Cited by 21

The Dual Nature of Microglia in Alzheimer’s Disease: A Microglia-Neuron Crosstalk Perspective

Xie, Z., Meng, J., Wu, Z., Nakanishi, H., Hayashi, Y., Kong, W., Lan, F., Narengaowa, Yang, Q., Qing, H., et al. (2023) · The Neuroscientist · doi:10.1177/10738584211070273 · Cited by 19

Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer’s disease transgenic mouse model

Lau, J. K. Y., Tian, M., Shen, Y., Lau, S., Fu, W., Fu, A. K. Y., & Ip, N. Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-83932-4 · Cited by 19

Brain interleukins and Alzheimer’s disease

Abdelhamed, H. G., Hassan, A. A., Sakraan, A., Al-Deeb, R. T., Mousa, D. M., Ezz, H. S. A., Noor, N. A., Khadrawy, Y. A., & Radwan, N. M. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01538-5 · Cited by 20

Glia–immune interactions post-ischemic stroke and potential therapies

Hersh, J., & Yang, S. (2018) · Experimental Biology and Medicine · doi:10.1177/1535370218818172 · Cited by 18

Unraveling the Immune Puzzle: Role of Immunomodulation in Alzheimer’s Disease

Ashvin, Dhapola, R., Kumari, S., Sharma, P., Vellingiri, B., Medhi, B., & HariKrishnaReddy, D. (2025) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-025-10210-9 · Cited by 19

Amyloid Cascade into Clarity

Weitz, T. M., & Town, T. (2016) · Immunity · doi:10.1016/j.immuni.2016.10.006 · Cited by 17

Neuroimmune interactions in Alzheimer's disease—New frontier with old challenges?

Prokop, S., Lee, V. M. ‐., & Trojanowski, J. Q. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.10.002 · Cited by 17

Key brain cell interactions and contributions to the pathogenesis of Alzheimer’s disease

Saavedra, J., Nascimento, M., Liz, M. A., & Cardoso, I. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1036123 · Cited by 16

Cordyceps militaris Extract and Cordycepin Alleviate Oxidative Stress, Modulate Gut Microbiota and Ameliorate Intestinal Damage in LPS-Induced Piglets

Xiong, S., Jiang, J., Wan, F., Tan, D., Zheng, H., Xue, H., Hang, Y., Yang, L., & Su, Y. (2024) · Antioxidants · doi:10.3390/antiox13040441 · Cited by 16

Neurobartonelloses: emerging from obscurity!

Bush, J. C., Robveille, C., Maggi, R. G., & Breitschwerdt, E. B. (2024) · Parasites & Vectors · doi:10.1186/s13071-024-06491-3 · Cited by 16

Perturbation of the transcriptome: implications of the innate immune system in Alzheimer's disease

Song, F., Qian, Y., Peng, X., Han, G., Wang, J., Bai, Z., Crack, P. J., & Lei, H. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.09.015 · Cited by 17

Normal aging, motor neurone disease, and Alzheimer’s disease are characterized by cortical changes in inflammatory cytokines

Tennakoon, A., Katharesan, V., Musgrave, I., Koblar, S. A., Faull, R. L. M., Curtis, M. A., & Johnson, I. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24996 · Cited by 17

Hippocampal but Not Serum Cytokine Levels Are Altered by Traffic-Related Air Pollution in TgF344-AD and Wildtype Fischer 344 Rats in a Sex- and Age-Dependent Manner

Patten, K. T., Valenzuela, A. E., Wallis, C., Harvey, D. J., Bein, K. J., Wexler, A. S., Gorin, F. A., & Lein, P. J. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.861733 · Cited by 17

Association of IL-10 gene promoter polymorphisms with susceptibility to pseudoexfoliation syndrome, pseudoexfoliative and primary open-angle glaucoma

Fakhraie, G., Parvini, F., Ghanavi, J., Saif, S., & Farnia, P. (2020) · BMC Medical Genetics · doi:10.1186/s12881-020-0969-6 · Cited by 16

Role of interleukin 1-beta in the inflammatory response in a fatty acid amide hydrolase-knockout mouse model of Alzheimer’s disease

Aparicio, N., Grande, M. T., Esteban, S. R. D. M., López, A., Ruiz‐Pérez, G., Amores, M., Vázquez, C., Martínez-Relimpio, A. M., Pazos, M. R., Cravatt, B. F., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.09.009 · Cited by 16

Interleukin-33 regulates the functional state of microglia

Xiong, T., Wang, X., Zha, Y., & Wang, Y. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1012968 · Cited by 18

Micheliolide attenuates neuroinflammation to improve cognitive impairment of Alzheimer's disease by inhibiting NF-κB and PI3K/Akt signaling pathways

Yang, G., Hu, Y., Qin, X., Sun, J., Miao, Z., Wang, L., Ke, Z., & Zheng, Y. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17848 · Cited by 16

Cerebrospinal Fluid Cytokines in Patients with Neurosyphilis: The Significance of Interleukin‐10 for the Disease

Li, W., Wu, W., Chang, H., Jiang, M., Gao, J., Xu, Y., Xu, D., Yin, L., & Zhang, X. (2020) · BioMed Research International · doi:10.1155/2020/3812671 · Cited by 36

Identification of potential therapeutic and diagnostic characteristics of Alzheimer disease by targeting the miR-132-3p/FOXO3a-PPM1F axis in APP/PS1 mice

Fu, X., Liu, J., Xie, J., Chen, G., Zhang, H., Meng, F., Wu, M., Li, Q., Liu, Y., Wang, W., et al. (2022) · Brain Research · doi:10.1016/j.brainres.2022.147983 · Cited by 13

Interplay between the catecholaminergic enzymatic axis and neurodegeneration/neuroinflammation processes in the Alzheimer's disease continuum

Motta, C., Assogna, M., Bonomi, C. G., Lorenzo, F. D., Nuccetelli, M., Mercuri, N. B., Koch, G., & Martorana, A. (2023) · European Journal of Neurology · doi:10.1111/ene.15691 · Cited by 15

Multitasking Microglia and Alzheimer’s Disease: Diversity, Tools and Therapeutic Targets

Grubman, A., Kanninen, K. M., & Malm, T. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0825-5 · Cited by 14

Production, Mechanisms, and Therapeutic Strategies of Tryptophan Metabolites in CNS Diseases

Shi, C., Dong, J., Hui, X., Xu, Z., Zhao, Z., & Dong, L. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05538-5 · Cited by 19

Molecular systems evaluation of oligomerogenic APPE693Q and fibrillogenic APPKM670/671NL/PSEN1Δexon9 mouse models identifies shared features with human Alzheimer’s brain molecular pathology

Readhead, B., Haure‐Mirande, J., Zhang, B., Haroutunian, V. H., Gandy, S., Schadt, E. E., Dudley, J. T., & Ehrlich, M. E. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.167 · Cited by 15

Male adolescents with Interleukin 10 rs1800872 AA genotype had higher prevalence and slower recoveries of post-traumatic stress disorder at late stage of a follow-up

Chen, Y. L., Zheng, Y. J., Shen, Y. L., Guo, Q., Xu, C., Lin, J., & Fang, D. Z. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136411 · Cited by 14

A computational model of Alzheimer's disease at the nano, micro, and macroscales

Chamberland, É., Moravveji, S., Doyon, N., & Duchesne, S. (2024) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2024.1348113 · Cited by 15

Euonymus alatus Leaf Extract Attenuates Effects of Aging on Oxidative Stress, Neuroinflammation, and Cognitive Impairment

Gurung, P., Lim, J., Magar, T. B. T., Shrestha, R., & Kim, Y. (2024) · Antioxidants · doi:10.3390/antiox13040433 · Cited by 14

Exploring the relationship between lipid metabolism and cognition in individuals living with stable-phase Schizophrenia: a small cross-sectional study using Olink proteomics analysis

Zheng, Y., Cai, X., Wang, D., Chen, X., Wang, T., Xie, Y., Li, H., Wang, T., He, Y., Li, J., et al. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-06054-x · Cited by 17

Molecular mechanisms of sulforaphane in Alzheimer’s disease: insights from an in-silico study

Vu, G. H., & Nguyen, H. D. (2024) · In Silico Pharmacology · doi:10.1007/s40203-024-00267-4 · Cited by 15

IL-33 and IL-10 Serum Levels Increase in MCI Patients Following Homotaurine Treatment

Toppi, E., Sireno, L., Lembo, M., Banaj, N., Messina, B., Golesorkhtafti, S., Spalletta, G., & Bossù, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.813951 · Cited by 14

Therapeutic Targets in Innate Immunity to Tackle Alzheimer’s Disease

Serradas, M. L., Ding, Y., Martorell, P., Kulińska, I., & Castro‐Gomez, S. (2024) · Cells · doi:10.3390/cells13171426 · Cited by 16

Differences in Immune-Related Genes Underlie Temporal and Regional Pathological Progression in 3xTg-AD Mice

Fernandes, A. M. A., Caldeira, C., Cunha, C., Ferreiro, E. B., Vaz, A. R., & Brites, D. M. T. O. (2022) · Cells · doi:10.3390/cells11010137 · Cited by 14

Update on the role of T cells in cognitive impairment

Ruiz‐Fernández, I., Sánchez‐Díaz, R., Ortega‐Sollero, E., & Martı́n, P. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16214 · Cited by 14

Depressive-like Behavior Is Accompanied by Prefrontal Cortical Innate Immune Fatigue and Dendritic Spine Losses after HIV-1 Tat and Morphine Exposure

Nass, S. R., Hahn, Y. K., Ohene‐Nyako, M., McLane, V. D., Damaj, M. I., Thacker, L. R., Knapp, P. E., & Hauser, K. F. (2023) · Viruses · doi:10.3390/v15030590 · Cited by 12

The neuroprotection of deproteinized calf blood extractives injection against Alzheimer's disease via regulation of Nrf-2 signaling

Qu, Y., Wang, W., Chen, T., Yang, Y., Zhang, Y., & Wang, D. (2021) · Aging · doi:10.18632/aging.202776 · Cited by 12

GM1 ganglioside modifies microglial and neuroinflammatory responses to α-synuclein in the rat AAV-A53T α-synuclein model of Parkinson's disease

Schneider, J. S., Singh, G., Williams, C. K., & Singh, V. (2022) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2022.103729 · Cited by 11

Defining Trends in Global Gene Expression in Arabian Horses with Cerebellar Abiotrophy

Scott, E., Penedo, M. C. T., Murray, J. D., & Finno, C. J. (2016) · The Cerebellum · doi:10.1007/s12311-016-0823-8 · Cited by 12

Active Fraction Combination from Liuwei Dihuang Decoction (LW-AFC) Alleviated the LPS-Induced Long-Term Potentiation Impairment and Glial Cells Activation in Hippocampus of Mice by Modulating Immune Responses

Ju, Z., Cheng, B., Huang, Y. Y., Zhang, X., Wang, C., Sun, N., Liu, G., Cheng, X., Zhang, Y., & Zhou, W. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/3040972 · Cited by 12

Contextualizing the Role of Osteopontin in the Inflammatory Responses of Alzheimer’s Disease

Lalwani, R. C., Volmar, C., Wahlestedt, C., Webster, K. A., & Shehadeh, L. A. (2023) · Biomedicines · doi:10.3390/biomedicines11123232 · Cited by 13

Carboxymethylcellulose encapsulated fingolimod, siRNA@ZnO hybrid nanocomposite as a new anti-Alzheimer's material

Aljohani, N. B., Qusti, S. Y., Alsiny, M., Aljoud, F., Aljohani, N. B., Alsolami, E. S., Alamry, K. A., & Hussein, M. A. (2024) · RSC Advances · doi:10.1039/d4ra01965b · Cited by 11

Gene therapy-mediated enhancement of protective protein expression for the treatment of Alzheimer’s disease

Owens, L., Benedetto, A., Dawson, N., Gaffney, C. J., & Parkin, E. T. (2021) · Brain Research · doi:10.1016/j.brainres.2020.147264 · Cited by 11

Innovations advancing our understanding of microglia in Alzheimer's disease: From in vitro to in vivo models

Maksour, S., & Ooi, L. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15885 · Cited by 12

Mouse models in modeling aging and cancer

Li, H., Wei, C., Zhou, R., Wang, B., Zhang, Y., Shao, C., & Luo, Y. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.03.002 · Cited by 11

Inflammatory and Infectious Processes Serve as Links between Atrial Fibrillation and Alzheimer’s Disease

Martins, G. L., Duarte, R. C. F., Mukhamedyarov, M. A., Palotás, A., Ferreira, C. N., & Reis, H. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093226 · Cited by 12

The structural simplification of lysergic acid as a natural lead for synthesizing novel anti-Alzheimer agents

Alzweiri, M. H., Alsegiani, A. S., Karaj, E., Almarghalani, D. A., Tabaza, Y., Shah, Z. A., & Tillekeratne, L. M. V. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.128205 · Cited by 13

Targeting immune cells in the aged brain reveals that engineered cytokine IL-10 enhances neurogenesis and improves cognition

Negredo, P. N., You, J., Hauptschein, M., Schroer, A. B., Richard, D. J., Abhiraman, G. C., Tsai, A. P., Sun, E., Notarangelo, G., Ramirez-Matias, J., et al. (2026) · Immunity · doi:10.1016/j.immuni.2026.01.016 · Cited by 12

Electromagnetic pulse exposure induces neuroinflammation and blood-brain barrier disruption by activating the NLRP3 inflammasome/NF-κB signaling pathway in mice

Lin, Y., Lang, H., Gao, P., Miao, X., Guo, Q., Hao, Y., Ai, T., Li, J., Zhang, J., & Guo, G. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.117972 · Cited by 10

Roles of Microglia in AD Pathology

Gao, R., Wu, H., Li, Q., & Zhao, J. (2023) · Current Alzheimer Research · doi:10.2174/1567205020666230203112351 · Cited by 10

Recent Progress in the Drug Development for the Treatment of Alzheimer’s Disease Especially on Inhibition of Amyloid-peptide Aggregation

Liu, Y., Cong, L., Han, C., Li, B., & Dai, R. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520666201127104539 · Cited by 10

Microglial polarization differentially affects neuronal vulnerability to the β-amyloid protein: Modulation by melatonin

Merlo, S., Caruso, G. I., Bonfili, L., Spampinato, S. F., Costantino, G., Eleuteri, A. M., & Sortino, M. A. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115151 · Cited by 10

Involvement of IL-10R/STAT3 pathway in amyloid β clearance by microlgia in Alzheimer's disease

Liu, H., Zhou, Y., & Song, W. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108263 · Cited by 9

Peripheral Immune Cells and Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease Pathology in Cognitively Intact Older Adults: The CABLE Study

Zhang, P.-F., Wang, Z.-T., Liu, Y., Hu, H., Sun, Y., Hu, H.-Y., Ma, Y.-H., Tan, L., & Yu, J.-T. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220057 · Cited by 9

Effects of diverse Types of Toxoplasma gondii on the outcome of Alzheimer's disease in the rat model

Galeh, T. M., Ghazvini, H., Mohammadi, M., Sarvi, S., Azizi, S., Asgarian‐Omran, H., Hajizadeh, F., & Daryani, A. (2022) · Microbial Pathogenesis · doi:10.1016/j.micpath.2022.105931 · Cited by 9

Association of preoperative to postoperative change in cerebrospinal fluid fibrinogen with postoperative delirium

Payne, T., Taylor, J., Kunkel, D., Konieczka, K., Ingram, F., Blennow, K., Zetterberg, H., Pearce, R. A., Meyer‐Franke, A., Terrando, N., et al. (2024) · BJA Open · doi:10.1016/j.bjao.2024.100349 · Cited by 8

Acute experimental colitis in 5xFAD Alzheimer's disease mice leads to enhanced monocyte infiltration into the brain accompanied by reduced β‐amyloid deposition

Shanmugam, N. K. N., Zamudio, F., Kumar, D. K. V., Barrett, K. A., VanDoren, R., Chen, M., Barr, O. M., Watson, S., Lin, C., Eimer, W. A., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70292 · Cited by 8

Immunotherapeutic effects of lymphocytes co-cultured with human cord blood-derived multipotent stem cells transplantation on APP/PS1 mice

He, Y., Li, H., Zhang, F., Zhang, G., Tang, X., Zhu, T., Huang, N., & Li, X. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.08.025 · Cited by 8

Immunoproteasome Subunit Low Molecular Mass Peptide 2 (LMP2) Deficiency Ameliorates LPS/Aβ1-42-Induced Neuroinflammation

Guo, Y., Wang, S., Li, L., Zhang, H., Chen, X., Huang, Z., & Liu, Y. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03564-9 · Cited by 8

Genetic Ablation of Hematopoietic Cell Kinase Accelerates Alzheimer’s Disease–Like Neuropathology in Tg2576 Mice

Lim, S., Tran, D. N., Kieu, Z., Chen, C., Villanueva, E., Ghiaar, S., Gallup, V., Zumkehr, J., Cribbs, D. H., Rodríguez‐Ortiz, C. J., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01894-6 · Cited by 8

Novel Balance Mechanism Participates in Stem Cell Therapy to Alleviate Neuropathology and Cognitive Impairment in Animal Models with Alzheimer’s Disease

Qin, C., Li, Y., & Wang, K. (2021) · Cells · doi:10.3390/cells10102757 · Cited by 8

High-Intense Interval Training Prevents Cognitive Impairment and Increases the Expression of Muscle Genes FNDC5 and PPARGC1A in a Rat Model of Alzheimer's Disease

Godinho, W. D. N., Vasconcelos-Filho, F. S. L., Pinto, D. V., Alves, J. O., Nascimento, T. D. S., de Aguiar, I. D., Almeida, G. N. S., Ceccatto, V. M., & Soares, P. M. (2022) · Current Alzheimer Research · doi:10.2174/1567205020666221207103109 · Cited by 7

The NLRP3-P2X7 Axis and Cytokine Crosstalk in Alzheimer's Disease: Mechanisms, Implications, and Therapeutic Opportunities

Kurmi, S., Doshi, G., & Parab, S. B. (2025) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273377780250505115039 · Cited by 7

The effect and mechanism of palmar ginseng in type 2 diabetic cognitive impairment

Yong, S., Yuhan, Z., Shan-shan, C., Xin, W., Leilei, S., & Liu, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32525 · Cited by 7

Promoter haplotypes of interleukin-10 gene linked to cortex plasticity in subjects with risk of Alzheimer's disease

Bai, F., Xie, C., Yuan, Y., Shi, Y., & Zhang, Z. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.11.019 · Cited by 7

Isoflurane anesthesia impairs the expression of immune neuromodulators in the hippocampus of aged mice

Friese, M. B., Nathan, M., Culley, D. J., & Crosby, G. J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0209283 · Cited by 7

Nootropic Effects of 7-Isoprenyloxycoumarin and Herniarin from Tagetes lucida on Lipopolysaccharide-Induced Neuroinflammation

Monterrosas‐Brisson, N., Jiménez‐Ferrer, E., Rafael, B.-P., González‐Cortazar, M., Porras‐Dávila, S. L., Maruri, D. T., Martínez-Duncker, I., & Herrera-Ruiz, M. L. (2024) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-024-00518-7 · Cited by 6

Relationships of Low Serum Levels of Interleukin-10 With Poststroke Anxiety and Cognitive Impairment in Patients With Clinical Acute Stroke

Ying, Z., Huang, Y., Shao, M., Chi, C., Jiang, M., Chen, Y., Yuchen, Sun, M.-X., Zhu, Y.-Y., & Li, X. (2023) · Journal of Clinical Neurology · doi:10.3988/jcn.2022.0151 · Cited by 6

The association of microbial infection and adaptive immune cell activation in Alzheimer’s disease

Clement, M. (2023) · Discovery Immunology · doi:10.1093/discim/kyad015 · Cited by 6

Onset of Alzheimer disease in apolipoprotein ɛ4 carriers is earlier in butyrylcholinesterase K variant carriers

Lane, R. M., Darreh‐Shori, T., Junge, C., Li, D. X., Yang, Q., Edwards, A., Graham, D. L., Moore, K. M., & Mummery, C. J. (2024) · BMC Neurology · doi:10.1186/s12883-024-03611-5 · Cited by 5

Modulating innate immune activation states impacts the efficacy of specific Aβ immunotherapy

Levites, Y., Funk, C. C., Wang, X., Chakrabarty, P., McFarland, K. N., Bramblett, B., O’Neal, V., Liu, X., Ladd, T. B., Robinson, M., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00453-4 · Cited by 6

Ablation of interleukin-19 improves motor function in a mouse model of amyotrophic lateral sclerosis

Komiya, H., Takeuchi, H., Ogawa, Y., Suzuki, K., Ogasawara, A., Takahashi, K., Azuma, Y., Doi, H., & Tanaka, F. (2021) · Molecular Brain · doi:10.1186/s13041-021-00785-8 · Cited by 7

Inflammation in Alzheimer’s disease: do sex and APOE matter?Preprint

Duarte‐Guterman, P., Albert, A., Inkster, A. M., Barha, C. K., Galea, L. A. M., & Initiative, O. B. O. T. A. D. N. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/741777 · Cited by 4

Shared Genetic Etiology between Alzheimer’s Disease and Blood Levels of Specific Cytokines and Growth Factors

van der Linden, R. J., Witte, W. D., & Poelmans, G. (2021) · Genes · doi:10.3390/genes12060865 · Cited by 5

Neuroimmune Response Mediated by Cytokines in Natural Scrapie after Chronic Dexamethasone Treatment

Guijarro, I. M., Garcés, M., Andrés‐Benito, P., Marín, B., Otero, A., Barrio, T., Carmona, M., Ferrer, I., Badiola, J. J., & Monzón, M. (2021) · Biomolecules · doi:10.3390/biom11020204 · Cited by 5

Utility of combined inflammatory biomarkers for the identification of cognitive dysfunction in non-diabetic participants of the ELSA-Brasil

Cezaretto, A., de Almeida-Pititto, B., Alencar, G. P., Suemoto, C. K., Benseñor, I. M., Lotufo, P. A., & Ferreira, S. R. G. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.01.003 · Cited by 5

Bonyzymes: Efficient Anti‐Inflammatory, Antibacterial and Osteogenic Agents for Peri‐Implantitis Reconstruction Treatment

Liu, G., Wu, X., Tan, L., Cheng, T., Yang, C., Liu, X., He, F., Tang, Z., Yan, Q., Fu, L., et al. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202503585 · Cited by 4

The Role of T Cells in Alzheimer's Disease Pathogenesis

Zhao, J., Wang, X., He, Y., Xu, P., Lai, L., Chung, Y., & Pan, X. (2023) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2023050145 · Cited by 4

Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Guillot‐Sestier, M., Weitz, T. M., & Town, T. (2016) · Journal of Visualized Experiments · doi:10.3791/54868 · Cited by 4

Analyzing microglial-associated Aβ in Alzheimer’s disease transgenic mice with a novel mid-domain Aβ-antibody

Henjum, K., Årskog, V., Jendresen, C., Fladby, T., Torp, R., & Nilsson, L. N. G. (2020) · Scientific Reports · doi:10.1038/s41598-020-67419-2 · Cited by 4

O2‐05‐02: Il10 deficiency licenses innate immunity to fight against cerebral amyloidosis

Guillot‐Sestier, M., Doty, K. R., Gate, D., Rodríguez, J., Leung, B. C. L., Rezai-Zadeh, K. P., & Town, T. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.07.155 · Cited by 1

IL-10 Alters Immunoproteostasis in APP Mice, Increasing Plaque Burden and Worsening Cognitive Behavior

Chakrabarty, P., Li, A., Ceballos-Diaz, C., Eddy, J. A., Funk, C. C., Moore, B., DiNunno, N., Rosario, A. M., Cruz, P. E., Verbeeck, C., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.11.020 · Cited by 354

Anti-inflammatory Signaling in Microglia Exacerbates Alzheimer’s Disease-Related Pathology

Michaud, J.-P., & Rivest, S. (2015) · Neuron · doi:10.1016/j.neuron.2015.01.021 · Cited by 69

P1‐324: TGF‐β and IL‐10: An Alzheimer immunoregulatory duet?

Rezai-Zadeh, K. P., Gate, D., Rentsendorj, A., Jodry, D., Mori, T., Szekely, C. A., Tan, J., & Town, T. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.05.877

P4‐337: Reducing Alzheimer's disease beta‐amyloid and cognitive deficits by manipulating il‐12/il‐23 signaling

Obst, J., Prokop, S., Berg, J. V., Miller, K., Kälin, R. E., Cabezas, I. L., Wegner, A., Mair, F., Winter, Y., Becher, B., et al. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.08.118